| Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders P Shahabi, G Siest, UA Meyer, S Visvikis-Siest Pharmacology & therapeutics 144 (2), 134-161, 2014 | 100 | 2014 |
| Assessment of patients after coronary artery bypass grafting using 64-slice computed tomography I Nazeri, P Shahabi, M Tehrai, B Sharif-Kashani, A Nazeri The American journal of cardiology 103 (5), 667-673, 2009 | 57 | 2009 |
| Incidence of fever and bacteriemia following flexible fiberoptic bronchoscopy: a prospective study B Sharif-Kashani, P Shahabi, N Behzadnia, Z Mohammad-Taheri, ... Acta Medica Iranica, 385-388, 2010 | 35 | 2010 |
| Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids P Shahabi, G Siest, S Visvikis-Siest Drug Metabolism Reviews 46 (1), 33-56, 2014 | 33 | 2014 |
| Smoking and wound complications after coronary artery bypass grafting B Sharif-Kashani, P Shahabi, MH Mandegar, L Saliminejad, B Bikdeli, ... journal of surgical research 200 (2), 743-748, 2016 | 31 | 2016 |
| Impact of calcification on diagnostic accuracy of 64-slice spiral computed tomography for detecting coronary artery disease: a single center experience I Nazeri, P Shahabi, M Tehrai, KB SHARIF, AR NAZERI ARCHIVES OF IRANIAN MEDICINE 13 (5), 373-383, 2010 | 31 | 2010 |
| Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study S Perreault, P Shahabi, R Côté, S Dumas, É Rouleau‐Mailloux, ... Clinical Cardiology 41 (5), 576-585, 2018 | 23 | 2018 |
| An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance P Shahabi, LB Scheinfeldt, DE Lynch, TJ Schmidlen, S Perreault, ... Thrombosis and haemostasis 116 (08), 337-348, 2016 | 21 | 2016 |
| Characterization of a needle-type giant magnetoresistance sensor for detection of escherichia coli’s magnetic marker H Shirzadfar, M Nadi, D Kourtiche, S Yamada, P Shahabi International Journal on Smart Sensing and Intelligent Systems 8 (1), 220-234, 2015 | 21 | 2015 |
| Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999 P Shahabi, G Siest, B Herbeth, NC Ndiaye, S Visvikis-Siest Clinica Chimica Acta 413 (19-20), 1618-1624, 2012 | 19 | 2012 |
| Screening for deep vein thrombosis in asymptomatic high-risk patients: a comparison between digital photoplethysmography and venous ultrasonography B Sharif-Kashani, N Behzadnia, P Shahabi, M Sadr Angiology 60 (3), 301-307, 2009 | 19 | 2009 |
| Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice P Shahabi, MP Dube International Journal of cardiology 184, 772-795, 2015 | 17 | 2015 |
| Impact of regular physical activity on weekly warfarin dose requirement E Rouleau-Mailloux, P Shahabi, S Dumas, Y Feroz Zada, S Provost, J Hu, ... Journal of Thrombosis and Thrombolysis 41, 328-335, 2016 | 16 | 2016 |
| Sticker reminders improve thromboprophylaxis appropriateness in hospitalized patients B Sharif-Kashani, S Raeissi, B Bikdeli, P Shahabi, N Behzadnia, ... Thrombosis research 126 (3), 211-216, 2010 | 14 | 2010 |
| AssessMent of ProphylAxis for VenouS ThromboembolIsm in hospitalized patients: the MASIH study B Sharif-Kashani, P Shahabi, S Raeissi, N Behzadnia, A Shoaraka, ... Clinical and Applied Thrombosis/Hemostasis 18 (5), 462-468, 2012 | 11 | 2012 |
| Insertion/deletion gene polymorphism and serum level of angiotensin converting enzyme F MOHAMMADI, P Shahabi, S Zabani, AA ZIAEI TANAFFOS 7 (2), 18-22, 2008 | 10 | 2008 |
| Comparison of three risk assessment methods for venous thromboembolism prophylaxis B Bikdeli, B Sharif-Kashani, P Shahabi, S Raeissi, M Shahrivari, ... Blood Coagulation & Fibrinolysis 24 (2), 157-163, 2013 | 9 | 2013 |
| Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension N Behzadnia, K Najafizadeh, B Sharif-Kashani, DO Dameshghi, ... Heart and vessels 25, 313-318, 2010 | 8 | 2010 |
| Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort P Shahabi, F Lamothe, S Dumas, É Rouleau-Mailloux, Y Feroz Zada, ... The Pharmacogenomics Journal 19 (2), 147-156, 2019 | 6 | 2019 |
| Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin P Shahabi, G Siest, S Visvikis-Siest Pharmacogenomics 13 (11), 1215-1218, 2012 | 5 | 2012 |
